Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacodynamics
3 evidence topics · 3 sources
Cerebrospinal fluid biomarkers after 52 weeks of treatment
Target engagement in mouse and cat models: company nonclinical studies
Intracisternal administration in cats with Niemann-Pick disease type C1
“In contrast, direct administration of HPβCD into the cisterna magna of presymptomatic cats with NPC disease prevented the onset of cerebellar dysfunction for greater than a year and resulted in a reduction in Purkinje cell loss and near normal concentrations of cholesterol and sphingolipids.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Moreover, administration of intracisternal HPβCD to NPC cats with ongoing cerebellar dysfunction slowed disease progression, increased survival time, and decreased the accumulation of brain gangliosides.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote